Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
Qi Zhang,1 Nan Hu2 1Department of Pharmacy, Changzhou No.7 People’s Hospital, Changzhou 213000, People’s Republic of China; 2Department of Pharmacy, The Third Affiliated Hospital of Soochow University, Changzhou 213000, People’s Republic of ChinaCorrespondence: Nan HuDe...
| Published in: | Diabetes, Metabolic Syndrome and Obesity |
|---|---|
| Main Authors: | Zhang Q, Hu N |
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2020-12-01
|
| Subjects: | |
| Online Access: | https://www.dovepress.com/effects-of-metformin-on-the-gut-microbiota-in-obesity-and-type-2-diabe-peer-reviewed-article-DMSO |
Similar Items
Effect of oral metformin on gut microbiota characteristics and metabolite fractions in normal-weight type 2 diabetic mellitus patients
by: Xiaohong Niu, et al.
Published: (2024-08-01)
by: Xiaohong Niu, et al.
Published: (2024-08-01)
The influence of metformin and empagliflozin administration on gut microbiota in individuals with type 2 diabetes mellitus and hypothyroidism
by: K.A. Moskva, et al.
Published: (2024-06-01)
by: K.A. Moskva, et al.
Published: (2024-06-01)
Gut microbiota’s role in the enhancement of type 2 diabetes treatment by a traditional Chinese herbal formula compared to metformin
by: Chengdong Xia, et al.
Published: (2025-05-01)
by: Chengdong Xia, et al.
Published: (2025-05-01)
Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
by: Alexander Sergeevich Ametov, et al.
Published: (2010-09-01)
by: Alexander Sergeevich Ametov, et al.
Published: (2010-09-01)
The role of metformin in the treatment of type 2 diabetes and obesity's
by: Vuković Mira H.
Published: (2016-01-01)
by: Vuković Mira H.
Published: (2016-01-01)
The Effects of Combined Insulin and Metformin Therapy in Obese Patients with Diabetes Mellitus Type 2 in the Early Stage of the Disease
by: Emela Mujić-Skikić, et al.
Published: (2008-08-01)
by: Emela Mujić-Skikić, et al.
Published: (2008-08-01)
Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?
by: Dzięgielewska-Gęsiak S, et al.
Published: (2022-11-01)
by: Dzięgielewska-Gęsiak S, et al.
Published: (2022-11-01)
The effect of Chinese herbal formulas combined with metformin on modulating the gut microbiota in the amelioration of type 2 diabetes mellitus: A systematic review and meta-analysis
by: Yunxi Xu, et al.
Published: (2022-09-01)
by: Yunxi Xu, et al.
Published: (2022-09-01)
The new views on the state of the gut microbiota in obesity and diabetes mellitus type 2
by: Elena V. Pokrovskaya, et al.
Published: (2019-08-01)
by: Elena V. Pokrovskaya, et al.
Published: (2019-08-01)
Metformin in the therapy of type 2 diabetes mellitus bur dened by sarcopenic obesity in the elderly. Focus on pleiotropic effects
by: E. A. Troshina, et al.
Published: (2025-05-01)
by: E. A. Troshina, et al.
Published: (2025-05-01)
Alterations in the Gut Microbiota Composition in Obesity with and without Type 2 Diabetes: A Pilot Study
by: Wang X, et al.
Published: (2024-10-01)
by: Wang X, et al.
Published: (2024-10-01)
Influence of gut microbiota on the development of insulin resistance
by: T. Yu. Demidova, et al.
Published: (2022-06-01)
by: T. Yu. Demidova, et al.
Published: (2022-06-01)
Interplay between gut microbiota and tryptophan metabolism in type 2 diabetic mice treated with metformin
by: Yvhao Xie, et al.
Published: (2024-10-01)
by: Yvhao Xie, et al.
Published: (2024-10-01)
Combination of Oligofructose and Metformin Alters the Gut Microbiota and Improves Metabolic Profiles, Contributing to the Potentiated Therapeutic Effects on Diet-Induced Obese Animals
by: Qingzhong Li, et al.
Published: (2020-02-01)
by: Qingzhong Li, et al.
Published: (2020-02-01)
Prospects for the use of fecal microbiota transplantation in obese patients with Type 2 Diabetes Mellitus for weight loss and improvement of insulin sensitivity
by: E. V. Pokrovskaya, et al.
Published: (2021-02-01)
by: E. V. Pokrovskaya, et al.
Published: (2021-02-01)
Scrophulariae Radix-Atractylodes sinensis pair and metformin inhibit inflammation by modulating gut microbiota of high-fat diet/streptozotocin-induced diabetes in rats
by: Xiaoxia Guo, et al.
Published: (2022-11-01)
by: Xiaoxia Guo, et al.
Published: (2022-11-01)
Effectiveness of Metformin in the Prevention of Gestational Diabetes Mellitus in Obese Pregnant Women
by: Willian Barbosa Sales, et al.
Published: (2018-04-01)
by: Willian Barbosa Sales, et al.
Published: (2018-04-01)
Gut microbiota and therapy for obesity and type 2 diabetes
by: Luyao Zhang, et al.
Published: (2024-03-01)
by: Luyao Zhang, et al.
Published: (2024-03-01)
Gut microbiota is correlated with gastrointestinal adverse events of metformin in patients with type 2 diabetes
by: Yuxin Huang, et al.
Published: (2022-11-01)
by: Yuxin Huang, et al.
Published: (2022-11-01)
Metformin is the most recognized first choice drug for patients with type 2 diabetes mellitus
by: A. M. Mkrtumyan
Published: (2018-03-01)
by: A. M. Mkrtumyan
Published: (2018-03-01)
Role of gut microbiota in the pathogenesis of type 2 diabetes mellitus (literature review)
by: S.M. Koval, et al.
Published: (2021-12-01)
by: S.M. Koval, et al.
Published: (2021-12-01)
The role of the gut microbiota in the pathogenesis and therapy of type 2 diabetes mellitus
by: Aleksandra Madej, et al.
Published: (2024-01-01)
by: Aleksandra Madej, et al.
Published: (2024-01-01)
Corrigendum: The new views on the state of the gut microbiota in obesity and diabetes mellitus type 2 (Diabetes mellitus. 2019;22(3). doi: 10.14341/DM10194)
by: Elena V. Pokrovskaya, et al.
Published: (2019-10-01)
by: Elena V. Pokrovskaya, et al.
Published: (2019-10-01)
Effects of metformin on the gut microbiota: A systematic review
by: Pavlo Petakh, et al.
Published: (2023-11-01)
by: Pavlo Petakh, et al.
Published: (2023-11-01)
Gut Microbiota, LADA, and Type 1 Diabetes Mellitus: An Evolving Relationship
by: Andrea Piccioni, et al.
Published: (2023-02-01)
by: Andrea Piccioni, et al.
Published: (2023-02-01)
Metformin in patients with type 2 diabetes mellitus and heart failure: a review
by: Zofia M. Kułaczkowska, et al.
Published: (2021-04-01)
by: Zofia M. Kułaczkowska, et al.
Published: (2021-04-01)
Effects of use of metformin or combination of metformin and pioglitazone on oxidative stress in type 2 diabetes mellitus
by: Tuğçenur Temiz Gençoğlu Ayşe, et al.
Published: (2025-01-01)
by: Tuğçenur Temiz Gençoğlu Ayşe, et al.
Published: (2025-01-01)
Proteomic Profiling Identifies Distinct Regulation of Proteins in Obese Diabetic Patients Treated with Metformin
by: Awad Alshahrani, et al.
Published: (2023-09-01)
by: Awad Alshahrani, et al.
Published: (2023-09-01)
Lipidomics Profiling of Metformin-Induced Changes in Obesity and Type 2 Diabetes Mellitus: Insights and Biomarker Potential
by: Muhammad Mujammami, et al.
Published: (2023-12-01)
by: Muhammad Mujammami, et al.
Published: (2023-12-01)
The Gut Microbiota-Related Antihyperglycemic Effect of Metformin
by: Izabela Szymczak-Pajor, et al.
Published: (2025-01-01)
by: Izabela Szymczak-Pajor, et al.
Published: (2025-01-01)
Lutein augments the hypoglycemic effect of metformin through the gut microbiota-imidazole propionate axis in type 2 diabetic model mice
by: Kai Liu, et al.
Published: (2025-08-01)
by: Kai Liu, et al.
Published: (2025-08-01)
Compositional Alterations of Gut Microbiota in Patients with Diabetic Kidney Disease and Type 2 Diabetes Mellitus
by: He X, et al.
Published: (2022-03-01)
by: He X, et al.
Published: (2022-03-01)
Severity of gastrointestinal side effects of metformin tablet compared to metformin capsule in type 2 diabetes mellitus patients
by: Mansour Siavash, et al.
Published: (2017-01-01)
by: Mansour Siavash, et al.
Published: (2017-01-01)
Investigation of plasma asprosin and saliva levels in newly diagnosed type 2 diabetes mellitus patients treated with metformin
by: Nevzat Gozel, et al.
Published: (2021-02-01)
by: Nevzat Gozel, et al.
Published: (2021-02-01)
Effect of metformin therapy on vitamin D level in patients with type 2 diabetes mellitus
by: K.O. Masliy
Published: (2019-03-01)
by: K.O. Masliy
Published: (2019-03-01)
Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus
by: Jiaqiang Wu, et al.
Published: (2023-05-01)
by: Jiaqiang Wu, et al.
Published: (2023-05-01)
Additional Effect of Dietary Fiber in Patients with Type 2 Diabetes Mellitus Using Metformin and Sulfonylurea: An Open-Label, Pilot Trial
by: Seung-Eun Lee, et al.
Published: (2019-08-01)
by: Seung-Eun Lee, et al.
Published: (2019-08-01)
Advances in Understanding the Relationship between Gut Microbiota, Probiotics and Type 2 Diabetes Mellitus
by: Deng Xiaoling, et al.
Published: (2024-11-01)
by: Deng Xiaoling, et al.
Published: (2024-11-01)
Effect of Combination Therapy with Extended-Release Metformine and Glimepiride on Carbohydrate and Lipid Metabolism in Patients with Type 2 Diabetes Mellitus
by: V.I. Pankiv
Published: (2016-08-01)
by: V.I. Pankiv
Published: (2016-08-01)
DIABETES MELLITUS TYPE 2 TREATMENT IN CHILDREN AND ADOLESCENTS: METFORMIN AS A FIRST AGENT OF CHOICE
by: T. L. Kuraeva
Published: (2012-01-01)
by: T. L. Kuraeva
Published: (2012-01-01)
Similar Items
-
Effect of oral metformin on gut microbiota characteristics and metabolite fractions in normal-weight type 2 diabetic mellitus patients
by: Xiaohong Niu, et al.
Published: (2024-08-01) -
The influence of metformin and empagliflozin administration on gut microbiota in individuals with type 2 diabetes mellitus and hypothyroidism
by: K.A. Moskva, et al.
Published: (2024-06-01) -
Gut microbiota’s role in the enhancement of type 2 diabetes treatment by a traditional Chinese herbal formula compared to metformin
by: Chengdong Xia, et al.
Published: (2025-05-01) -
Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
by: Alexander Sergeevich Ametov, et al.
Published: (2010-09-01) -
The role of metformin in the treatment of type 2 diabetes and obesity's
by: Vuković Mira H.
Published: (2016-01-01)
